Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012802 |
---|---|
Receipt number | R000014953 |
Scientific Title | Evaluation of the clinical efficacy of anagliptin in type 2 diabetic patients with diabetic nephropathy. |
Date of disclosure of the study information | 2014/01/09 |
Last modified on | 2017/07/31 18:40:35 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/01/09 13:26:45 | ||
2 | Update | 2016/03/08 09:51:41 | Recruitment status |
|
3 | Update | 2016/12/27 10:52:39 | Last follow-up date Date analysis concluded |
|
4 | Update | 2016/12/27 10:53:47 | Date of closure to data entry Date trial data considered complete |
|
5 | Update | 2016/12/27 10:56:13 | Recruitment status |
|
6 | Update | 2017/07/31 12:40:16 | Name of primary person or sponsor Institute Organization Organization Organization |
|
7 | Update | 2017/07/31 18:40:35 | Organization Organization Name of secondary funder(s) Name of secondary funder(s) |